Wordt geladen...
Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.
The site of action of aminoglutethimide (AG) has been investigated. An initial study was performed on 10 postmenopausal patients with advanced breast cancer who had taken 1000 mg AG per day and 20 mg hydrocortisone (HC) twice daily (b.d.) for greater than 3 months. There was a 15.5 +/- 5.6 s.e.-fold...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group
1983
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2011397/ https://ncbi.nlm.nih.gov/pubmed/6221746 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|